Rethinking lipid mediators
- 1 August 2005
- journal article
- Published by Elsevier in The Lancet
- Vol. 366 (9486) , 618-620
- https://doi.org/10.1016/s0140-6736(05)67119-x
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1The Journal of Experimental Medicine, 2005
- Novel ? ? 3-derived local mediators in anti-inflammation and resolutionPharmacology & Therapeutics, 2005
- Formation and antiproliferative effect of prostaglandin E3 from eicosapentaenoic acid in human lung cancer cellsJournal of Lipid Research, 2004
- Cyclooxygenases: new forms, new inhibitors, and lessons from the clinicThe FASEB Journal, 2004
- Lipoxins: endogenous regulators of inflammationAmerican Journal of Physiology-Renal Physiology, 2004
- Novel Docosanoids Inhibit Brain Ischemia-Reperfusion-mediated Leukocyte Infiltration and Pro-inflammatory Gene ExpressionJournal of Biological Chemistry, 2003
- Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial CellsJournal of Biological Chemistry, 2003
- Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanesJournal of Clinical Investigation, 2001
- Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathwaysJournal of Clinical Investigation, 2001
- Prostaglandins, Aspirin-like Drugs and the Oedema of InflammationNature, 1973